ResMed Launches Next-generation ReSupply Solution
ResMed (NYSE: RMD) (ASX: RMD) today launched its automated ResMed ReSupply solution for all U.S. home medical equipment (HME) providers to increase sleep apnea patients’ long-term therapy adherence and improve patient satisfaction.
Patients enrolled in an automated resupply program are 50 percent less likely to stop PAP (positive airway pressure) therapy within the first year, according to a 2018 study. ResMed’s program goes one step further, automating enrollment as patients meet compliance requirements and letting patients choose their preferred contact method – text, email or live call. Patients can also order supplies through a web- or mobile-based patient portal.
HMEs are able to manage all their patients’ resupply needs from a single comprehensive dashboard so they can quickly identify, prioritize and assign tasks.
“The new resupply platform is simple and easy to use – everything you need is at your fingertips,” said Kera Tennyson, a PAP location manager at Advanced Medical Solutions, in Ann Arbor, Mich. “PAP is a lifelong commitment, so it’s important that we help support our patients’ therapy for the long term. ResMed ReSupply helps us do just that.”
“Automating the resupply process is critical to maximize patients’ success on therapy, as well as HMEs’ business efficiency,” said Raj Sodhi, ResMed’s SaaS president. “With Brightree offering an automated resupply solution for its HME customers, and ResMed now launching one for non-Brightree customers, HMEs using any billing platform can all enjoy the benefits of an easily managed resupply program.”
HMEs interested in a resupply program can contact their ResMed sales representative or visit resmed.com/resmedresupply . Brightree customers can visit https://www.brightree.com/add-on-solutions/patient-resupply/ .
Demos of both automated resupply programs will be available at Medtrade in Las Vegas, April 16–18 (ResMed Booth #527, Brightree Booth #317).
At ResMed (NYSE: RMD) (ASX: RMD) we pioneer innovative solutions that treat and keep people out of the hospital, empowering them to live healthier, higher-quality lives. Our cloud-connected medical devices transform care for people with sleep apnea, COPD and other chronic diseases. Our comprehensive out-of-hospital software platforms support the professionals and caregivers who help people stay healthy in the home or care setting of their choice. By enabling better care, we improve quality of life, reduce the impact of chronic disease and lower costs for consumers and healthcare systems in more than 120 countries. To learn more, visit ResMed.com and follow @ResMed.
About Business Wire
101 California Street, 20th Floor
CA 94111 San Francisco
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
L&T-INFOTECH/LYMBYC17.7.2019 09:09:03 CEST | Press release
LTI to Acquire Advanced Analytics Firm Lymbyc
TRAXENS17.7.2019 08:32:11 CEST | Press release
Traxens Closes €20M Series C Financing Round With Key Strategic Partners
EBURY-PARTNERS17.7.2019 08:32:11 CEST | Press release
Unicaja Banco signs strategic partnership with Ebury Partners
CA-ANDERSEN-TAX16.7.2019 22:29:12 CEST | Pressemeddelelse
Andersen Global træder ind i Senegal, udvider tilstedeværelse i Afrika
CA-GILEAD-SCIENCES,-INC.16.7.2019 22:07:11 CEST | Press release
Gilead Sciences to Release Second Quarter 2019 Financial Results on Tuesday, July 30, 2019
NY-MSCI16.7.2019 16:51:06 CEST | Press release
MSCI Schedules Investor Conference Call to Review Second Quarter 2019 Results
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.Visit our pressroom